Using an immunohistochemistry approach on a tissue microarray containing different tumor regions, Sartori et al. explored the correlation and prognostic value of HSP90 and EGFR expression in 214 cases of IDH (isocitrate dehydrogenase) wild-type GBM. Here, EGFR is linked to glioblastoma.